Literature DB >> 33010625

Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region.

Giuseppe Floresta1, Antonino N Fallica2, Giuseppe Romeo2, Valeria Sorrenti2, Loredana Salerno2, Antonio Rescifina2, Valeria Pittalà3.   

Abstract

The enzymatic family of heme oxygenase (HO) is accountable for heme breakdown. Among the two isoforms characterized to date, HO-2 is poorly investigated due to the lack of potent HO-2 chemical modulators and the greater attentiveness towards HO-1 isoform. In the present paper, we report the rational design and synthesis of HO-2 inhibitors achieved by modulating the volume of known HO-1 inhibitors. The inhibition preference has been moved from HO-1 to HO-2 by merely increasing the volume of the substituent in the western region of the inhibitors. Docking studies demonstrated that new derivatives soak differently in the two binding pockets, probably due to the presence of a Tyr187 residue in HO-2. These findings could be useful for the design of new selective HO-2 compounds.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Azalanstat; Heme oxygenase-1; Heme oxygenase-2; Imidazole derivatives; Structure-activity relationships; Western region

Year:  2020        PMID: 33010625     DOI: 10.1016/j.bioorg.2020.104310

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  2 in total

1.  From Far West to East: Joining the Molecular Architecture of Imidazole-like Ligands in HO-1 Complexes.

Authors:  Giuseppe Floresta; Antonino Nicolò Fallica; Vincenzo Patamia; Valeria Sorrenti; Khaled Greish; Antonio Rescifina; Valeria Pittalà
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-10

2.  Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent In Vitro Antiproliferative Activity.

Authors:  Antonino N Fallica; Valeria Sorrenti; Agata G D'Amico; Loredana Salerno; Giuseppe Romeo; Sebastiano Intagliata; Valeria Consoli; Giuseppe Floresta; Antonio Rescifina; Velia D'Agata; Luca Vanella; Valeria Pittalà
Journal:  J Med Chem       Date:  2021-09-02       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.